Skip to main content
Mark Frampton, MD, Pulmonology, Rochester, NY

MarkWFramptonMD

Pulmonology • Rochester, NY

Occupational & Environmental Lung Disease

Professor Emeritus, Medicine, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Frampton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Frampton's full profile

Already have an account?

  • Office

    601 Elmwood Ave
    # Box
    Rochester, NY 14642
    Phone+1 585-275-4861
    Fax+1 585-273-1058

Education & Training

  • University of Rochester
    University of RochesterFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
  • University at Buffalo
    University at BuffaloResidency, Internal Medicine, 1973 - 1976
  • New York University School of Medicine
    New York University School of MedicineClass of 1973

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1974 - 2027
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cardiovascular Function and Ozone Exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)  
    John R. Balmes, Philip A. Bromberg, Mark W. Frampton, Mehrdad Arjomandi, ScienceDirect

Press Mentions

  • Sugar Companies Say the Air Is Safe
    Sugar Companies Say the Air Is SafeJuly 8th, 2021
  • Policy News: June 28, 2021
    Policy News: June 28, 2021June 28th, 2021
  • EPA Chief Reinstates Scientific Advisory Board He Disbanded – US News & World Report
    EPA Chief Reinstates Scientific Advisory Board He Disbanded – US News & World ReportJune 18th, 2021
  • Join now to see all

Grant Support

  • Ozone Cardiovascular Effects In Genetically Susceptible PeopleNational Institute Of Environmental Health Sciences2010–2012
  • Multidisciplinary Training In Pulmonary ResearchNational Heart, Lung, And Blood Institute2001–2011
  • Cardiovascular Effects Of Ultrafine Particles In Genetically Susceptible SubjectsNational Institute Of Environmental Health Sciences2009–2010
  • Ultrafine Particle-Induced Oxidative StressNational Institute Of Environmental Health Sciences2004–2007
  • Exposure To Ultrafine Carbon Particles In Diabetes (UPDIABETES)National Center For Research Resources2005
  • Effects Of Particle Exposure On The Pulmonary Diffusing Capacity (UPDLCO)National Center For Research Resources2004–2005
  • Ultrafine Particle Exposure In HumansNational Institute Of Environmental Health Sciences2002–2005
  • Effects Of Exposure To 50ug/M3 Ultrafine Carbon Particles In Healthy SubjectsNational Center For Research Resources2004
  • Effects Of Breathing Ultrafine Particles At RESTNational Center For Research Resources2000–2002
  • Dose Response To Ultra FINE Carbon Particles W/ ExerciseNational Center For Research Resources2000–2002
  • Airway Effects Of Repeated Exposures To Ozone In Healthy And AsthmaticsNational Center For Research Resources1996–2001
  • AIR Pollution On Breathing Assessed By Lung Lavage In Healthy HumansNational Center For Research Resources1996–2001
  • Oxidant AIR Pollutants, Airway Inflammation, And Respiratory Host DefenseNational Institute Of Environmental Health Sciences1996–2000
  • Human Health Effects Of Repeated Exposures To OzoneNational Heart, Lung, And Blood Institute1993–1996
  • Mechanisms Of Airway Inflammation With Varying Responses To OzoneNational Center For Research Resources1992–1993

Dr. Mark Frampton, Dr. Mark Frampton, MD, Dr. M Frampton, Dr. Mark W Frampton